Cargando…
Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial
Little is known about arachidonic acid (ARA) and docosahexaenoic acid (DHA) requirements in toddlers. A longitudinal, double blind, controlled trial in toddlers (n = 133) age 13.4 ± 0.9 months (mean ± standard deviation), randomized to receive a DHA (200 mg/day) and ARA (200 mg/day) supplement (supp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622735/ https://www.ncbi.nlm.nih.gov/pubmed/28878181 http://dx.doi.org/10.3390/nu9090975 |
_version_ | 1783267974716588032 |
---|---|
author | Devlin, Angela M. Chau, Cecil M. Y. Dyer, Roger Matheson, Julie McCarthy, Deanna Yurko-Mauro, Karin Innis, Sheila M. Grunau, Ruth E. |
author_facet | Devlin, Angela M. Chau, Cecil M. Y. Dyer, Roger Matheson, Julie McCarthy, Deanna Yurko-Mauro, Karin Innis, Sheila M. Grunau, Ruth E. |
author_sort | Devlin, Angela M. |
collection | PubMed |
description | Little is known about arachidonic acid (ARA) and docosahexaenoic acid (DHA) requirements in toddlers. A longitudinal, double blind, controlled trial in toddlers (n = 133) age 13.4 ± 0.9 months (mean ± standard deviation), randomized to receive a DHA (200 mg/day) and ARA (200 mg/day) supplement (supplement) or a corn oil supplement (control) until age 24 months determined effects on neurodevelopment. We found no effect of the supplement on the Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III) cognitive and language composites and Beery–Buktenica Developmental Test of Visual–Motor Integration (Beery VMI) at age 24 months. Supplemented toddlers had higher RBC phosphatidylcholine (PC), phosphatidylethanolamine (PE), and plasma DHA and ARA compared to placebo toddlers at age 24 months. A positive relationship between RBC PE ARA and Bayley III Cognitive composite (4.55 (0.21–9.00), B (95% CI), p = 0.045) in supplemented boys, but not in control boys, was observed in models adjusted for baseline fatty acid, maternal non-verbal intelligence, and BMI z-score at age 24 months. A similar positive relationship between RBC PE ARA and Bayley III Language composite was observed for supplemented boys (11.52 (5.10–17.94), p < 0.001) and girls (11.19 (4.69–17.68), p = 0.001). These findings suggest that increasing the ARA status in toddlers is associated with better neurodevelopment at age 24 months. |
format | Online Article Text |
id | pubmed-5622735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56227352017-10-05 Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial Devlin, Angela M. Chau, Cecil M. Y. Dyer, Roger Matheson, Julie McCarthy, Deanna Yurko-Mauro, Karin Innis, Sheila M. Grunau, Ruth E. Nutrients Article Little is known about arachidonic acid (ARA) and docosahexaenoic acid (DHA) requirements in toddlers. A longitudinal, double blind, controlled trial in toddlers (n = 133) age 13.4 ± 0.9 months (mean ± standard deviation), randomized to receive a DHA (200 mg/day) and ARA (200 mg/day) supplement (supplement) or a corn oil supplement (control) until age 24 months determined effects on neurodevelopment. We found no effect of the supplement on the Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III) cognitive and language composites and Beery–Buktenica Developmental Test of Visual–Motor Integration (Beery VMI) at age 24 months. Supplemented toddlers had higher RBC phosphatidylcholine (PC), phosphatidylethanolamine (PE), and plasma DHA and ARA compared to placebo toddlers at age 24 months. A positive relationship between RBC PE ARA and Bayley III Cognitive composite (4.55 (0.21–9.00), B (95% CI), p = 0.045) in supplemented boys, but not in control boys, was observed in models adjusted for baseline fatty acid, maternal non-verbal intelligence, and BMI z-score at age 24 months. A similar positive relationship between RBC PE ARA and Bayley III Language composite was observed for supplemented boys (11.52 (5.10–17.94), p < 0.001) and girls (11.19 (4.69–17.68), p = 0.001). These findings suggest that increasing the ARA status in toddlers is associated with better neurodevelopment at age 24 months. MDPI 2017-09-06 /pmc/articles/PMC5622735/ /pubmed/28878181 http://dx.doi.org/10.3390/nu9090975 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Devlin, Angela M. Chau, Cecil M. Y. Dyer, Roger Matheson, Julie McCarthy, Deanna Yurko-Mauro, Karin Innis, Sheila M. Grunau, Ruth E. Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title | Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title_full | Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title_fullStr | Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title_full_unstemmed | Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title_short | Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial |
title_sort | developmental outcomes at 24 months of age in toddlers supplemented with arachidonic acid and docosahexaenoic acid: results of a double blind randomized, controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622735/ https://www.ncbi.nlm.nih.gov/pubmed/28878181 http://dx.doi.org/10.3390/nu9090975 |
work_keys_str_mv | AT devlinangelam developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT chaucecilmy developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT dyerroger developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT mathesonjulie developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT mccarthydeanna developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT yurkomaurokarin developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT innissheilam developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial AT grunauruthe developmentaloutcomesat24monthsofageintoddlerssupplementedwitharachidonicacidanddocosahexaenoicacidresultsofadoubleblindrandomizedcontrolledtrial |